Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.
about
MicroRNA Regulation of Epithelial to Mesenchymal TransitionRegulation of Wnt/β-catenin signaling by herpesvirusesModeling nasopharyngeal carcinoma in three dimensionsDrosophila Eye Model to Study Neuroprotective Role of CREB Binding Protein (CBP) in Alzheimer's Disease.Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis.High expression of Sox10 correlates with tumor aggressiveness and poor prognosis in human nasopharyngeal carcinoma.Breast cancer stem cells: are we ready to go from bench to bedside?β-Catenin is important for cancer stem cell generation and tumorigenic activity in nasopharyngeal carcinoma.NEDD4 is involved in acquisition of epithelial-mesenchymal transition in cisplatin-resistant nasopharyngeal carcinoma cells.Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer.CBP/Catenin antagonists: Targeting LSCs' Achilles heel.Epstein-Barr virus infection and nasopharyngeal carcinoma.miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4.MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.Correlations of the expressions of c-Jun and Egr-1 proteins with clinicopathological features and prognosis of patients with nasopharyngeal carcinoma.Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG.Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer
P2860
Q26771110-FB159E20-ED4E-4C1F-820A-3DDDEA442A69Q28079414-0CE868F8-8C12-44D7-B294-10A9BE14A49EQ33599243-5B9A650C-477E-43F5-A05E-3C26E32BCBFEQ35772931-E6869061-582E-4C86-8971-4F20BA21176FQ36610848-D25C4855-971A-4DD2-B1C3-7D39A7B1AB5BQ36729236-36F2E24E-D874-4ED0-9766-40529D43D3B0Q38696803-E051AB8E-2E35-49D8-A5FC-34032350DB46Q38796204-89DD7E76-48D0-46B4-AC3C-99A9643A797FQ38853517-D8C19A6D-7F2A-4B0F-89EA-3E5C248F4789Q39018415-CEBFC708-D570-46F1-AA50-476CA48F49A2Q39289235-FC0B1215-73F5-45C7-A3A8-11C91784138CQ40046633-B4C781B4-0A50-4103-9ACB-B02F1AE941ADQ42237944-46B7D454-D902-4238-953E-6DD9CA26A958Q47877936-F672E90C-B261-42B2-9AC4-5D59CAA45DDCQ51107780-19D1329F-6107-4046-BC24-6CEF9F4A1FCFQ55424304-CD518AB0-A8E4-48C7-8F81-0AF51BD4C6CAQ58197289-756BB358-1061-436E-8409-B07BA9C35398
P2860
Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Therapeutic targeting of CBP/β ...... arcinoma cells with cisplatin.
@ast
Therapeutic targeting of CBP/β ...... arcinoma cells with cisplatin.
@en
type
label
Therapeutic targeting of CBP/β ...... arcinoma cells with cisplatin.
@ast
Therapeutic targeting of CBP/β ...... arcinoma cells with cisplatin.
@en
prefLabel
Therapeutic targeting of CBP/β ...... arcinoma cells with cisplatin.
@ast
Therapeutic targeting of CBP/β ...... arcinoma cells with cisplatin.
@en
P2093
P2860
P50
P356
P1433
P1476
Therapeutic targeting of CBP/β ...... arcinoma cells with cisplatin.
@en
P2093
Anne Wing Mui Lee
George Sai Wah Tsao
King Chi Chan
Kwok Wai Lo
Lai Sheung Chan
Michael Kahn
Nai Ki Mak
Roger Kai Cheong Ngan
Timothy Tak Chun Yip
P2860
P2888
P356
10.1038/SREP09979
P407
P577
2015-04-21T00:00:00Z